NCT00358878 Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS) Status COMPLETED Phase PHASE3
NCT00337740 Banding Versus Propranolol for Primary Prophylaxis of Variceal Bleeding Status TERMINATED Phase PHASE3
NCT00332904 Effect of Betablocker or Aldosterone Antagonist Therapy on Patients With Liver Cirrhosis Status UNKNOWN Phase PHASE4
NCT00312910 Probiotics for the Prevention of Major Complications of Cirrhosis Status COMPLETED Phase NA
NCT00304551 A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC) Status COMPLETED Phase PHASE3
NCT00287235 Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS) Status COMPLETED Phase NA
NCT00281502 The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy Status UNKNOWN Phase PHASE2
NCT00273247 Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis Status COMPLETED Phase PHASE3
NCT00245310 Indocyangreen Elimination in Cirrhosis and Acute Liver Failure Status COMPLETED Phase N/A
NCT00243633 Characterization of Focal Liver Lesions by Real-time Contrast-enhanced Ultrasound Imaging (CEUS) Status COMPLETED Phase NA
NCT00039871 PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370) Status COMPLETED Phase PHASE3
NCT00006398 Prevention of Esophageal Varices by Beta-Adrenergic Blockers Status COMPLETED Phase PHASE3
NCT00006166 North American Study for the Treatment of Refractory Ascites (NASTRA) Status COMPLETED Phase PHASE3